Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FH-deficient”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableUnknownNCT03984149
What this trial is testing

Lipa Gene Mutation in PED-LIPIGEN (Pediatric FH Subjects)

Who this might be right for
Lysosomal Acid Lipase Deficiency
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) 1,000
Not applicableLooking for participantsNCT06439654
What this trial is testing

Atlantic Lipid Lowering Treatment Optimization Program

Who this might be right for
Familial HypercholesterolemiaLipoprotein Types--Lp System Lp(A) HyperlipoproteinemiaApolipoprotein B 100, Familial Defective+2 more
Atlantic Health System 250
Early research (Phase 1)Study completedNCT02071862
What this trial is testing

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

Who this might be right for
Solid TumorsTriple-Negative Breast CancerNon Small Cell Lung Cancer+7 more
Calithera Biosciences, Inc 210
Not applicableUnknownNCT05535829
What this trial is testing

Molecular Markers in Predicting Response to Treatment in FH-deficient RCC Patients

Who this might be right for
FH-Deficient RCCSystemic TreatmentsBiomarkers
RenJi Hospital 100
Testing effectiveness (Phase 2)UnknownNCT04146831
What this trial is testing

Sintilimab in FH-deficient Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaFH-deficientSintilimab
West China Hospital 37
Not applicableUnknownNCT05243173
What this trial is testing

Biomarkers of Response to Systemic Treatments in FH-deficient RCC

Who this might be right for
MetabolomicsRenal Cell CarcinomaFH-Deficient RCC+1 more
RenJi Hospital 100